Pharmaceuticals and Drug Development

Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Basilea Announces FDA Acceptance of New Drug Application for Antibiotic Ceftobiprole

Treatment for: Skin and Structure Infection Basilea Announces FDA Acceptance of New Drug Application for Antibiotic Ceftobiprole Seeking approval for Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP) Prescription Drug User Fee Act (PDUFA) goal date set for April 03, 2024 Allschwil, Switzerland, […]
Written by
Study Looks at Palliative Care Use in Adolescents, Young Adults With Cancer
  1. Pharmaceuticals and Drug Development

Study Looks at Palliative Care Use in Adolescents, Young Adults With Cancer

By Elana Gotkine HealthDay Reporter FRIDAY, Oct. 20, 2023 — For adolescents and young adults (AYA) with cancer, the likelihood of receiving specialty palliative care (SPC) is increased for those reporting moderate or severe symptoms, according to a study published online Oct. 20 in JAMA Network Open. Sumit Gupta, M.D., Ph.D., from The Hospital for […]
Written by
  1. Pharmaceuticals and Drug Development

Lib Dem MP weighs in on British scientific innovation

On National Manufacturing Day, September 28, Twickenham MP Munira Wilson met with locally based Easyfairs, the organisers of the UK’s largest trade annual trade shows for the laboratory and engineering industries: Lab Innovations and Advanced Engineering. Munira – who is also the Liberal Democrat education spokesperson – discussed the need for greater recruitment and education […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Penbraya (meningococcal groups A, B, C, W and Y vaccine) for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents

FDA Approves Penbraya (meningococcal groups A, B, C, W and Y vaccine) for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents NEW YORK–(BUSINESS WIRE) October 20, 2023 — Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Penbraya™ (meningococcal groups A, B, C, […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Coherus Announces Resubmission of Biologics License Application (BLA) Supplement for Udenyca ® OnBody™

Generic name: pegfilgrastim-cbqvTreatment for: Neutropenia Associated with Chemotherapy Coherus Announces Resubmission of Biologics License Application (BLA) Supplement for Udenyca ® OnBody™ REDWOOD CITY, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) today announced the Company has resubmitted the Biologics License Application (BLA) Supplement for UDENYCA® ONBODY™, the company’s on-body injector […]
Written by
Enzalutamide + Leuprolide Top for Mets-Free Survival in Prostate Cancer
  1. Pharmaceuticals and Drug Development

Enzalutamide + Leuprolide Top for Mets-Free Survival in Prostate Cancer

By Elana Gotkine HealthDay Reporter WEDNESDAY, Oct. 18, 2023 — For patients with prostate cancer with high-risk biochemical recurrence, enzalutamide plus leuprolide is best for metastasis-free survival, according to a study published in the Oct. 19 issue of the New England Journal of Medicine. Stephen J. Freedland, M.D., from the Cedars-Sinai Medical Center in Los […]
Written by
  1. Pharmaceuticals and Drug Development

Lab Innovations announces this year’s keynote speakers

Philbin, a renowned TV presenter and science and technology advocate, will take to the stage at the RSC theatre at 1 pm on day one of Lab Innovations. She will discuss the reasons behind her passion for innovation in the lab industry and share an insight into some of the latest projects to catch her […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Bimzelx (bimekizumab-bkzx) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis

FDA Approves Bimzelx (bimekizumab-bkzx) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis Brussels (Belgium), 18 OCTOBER 2023 – UCB, a global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Bimzelx® (bimekizumab-bkzx) for the treatment of moderate to severe plaque psoriasis in adults who are candidates for […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Sun Pharma Announces US FDA Filing Acceptance of New Drug Application for Deuruxolitinib

Treatment for: Alopecia Areata Sun Pharma Announces US FDA Filing Acceptance of New Drug Application for Deuruxolitinib Mumbai, INDIA and Princeton, N.J., October 06, 2023 – Sun Pharmaceutical Industries Ltd (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries or associate companies) today announced that the U.S. Food and […]
Written by

Good Reads

New tentative approval for Alembic drug dabigatran etexilate mesylate

New patent for Vanda Pharms drug HETLIOZ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are thirty patents protecting this drug and two Paragraph IV challenges. Drug patent litigation for HETLIOZ. This drug has one […]
Written by

A proteome-wide yeast degron collection for the dynamic study of protein function

Genome-wide collections of yeast strains, known as libraries, revolutionized the way systematic studies are carried out. Specifically, libraries that involve a cellular perturbation, such as the deletion collection, have facilitated key biological discoveries. However, short-term rewiring and long-term accumulation of suppressor mutations often obscure the functional consequences of such perturbations. We present the AID library […]
Written by

Worlwide

New tentative approval for Alembic drug dabigatran etexilate mesylate

New patent for Vanda Pharms drug HETLIOZ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are thirty patents protecting this drug and two Paragraph IV challenges. Drug patent litigation for HETLIOZ. This drug has one […]
Written by

A proteome-wide yeast degron collection for the dynamic study of protein function

Genome-wide collections of yeast strains, known as libraries, revolutionized the way systematic studies are carried out. Specifically, libraries that involve a cellular perturbation, such as the deletion collection, have facilitated key biological discoveries. However, short-term rewiring and long-term accumulation of suppressor mutations often obscure the functional consequences of such perturbations. We present the AID library […]
Written by

Columbia Climate School Hosts Ninth Annual Sustainability Careers Reception – State of the Planet

Practitioners who attended the 2024 Sustainability Careers Reception. (*See below for names and affiliations) Last month, the Columbia Climate School hosted its ninth annual Sustainability Careers Reception at the Columbia Club in Midtown Manhattan. Thirty-three sustainability professionals and 88 Columbia students from varying backgrounds and degree pursuits gathered to discuss the ever-pressing challenges and real-world […]
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.